|
Published by: Key Note Publications Ltd
Published: Dec. 1, 2007 - 149 Pages
Table of Contents
- Executive Summary
- 1. Introduction
- BACKGROUND
- DEFINITION
- SOURCES AND HEALTH BENEFITS OF VITAMINS, MINERALS AND SUPPLEMENTS
- Table 1: Recommended Daily Allowances for Vitamins and Minerals by Selected Age Groups and Sex (micrograms and milligrams)
- Table 2: Vitamins, Minerals and Supplements — Sources and Health Benefits
- 2. Strategic Overview
- MARKET DYNAMICS AND SEGMENTATION
- Factors Driving or Affecting the Market
- Demographic Trends: Age Profiles and Life Expectancy
- Table 3: Average Life Expectancy in the UK by Sex (years), 1900, 1971, 1976, 1981, 1986, 1991, 1996, 2001 and 2003
- Table 4: The UK Population by Age Group (% and million), 1971, 1981, 1991, 2001, 2005, 2011, 2021 and 2031
- Specific Health-Related Issues
- Regulatory Factors
- The Total Market
- Table 5: The Total Vitamins, Minerals and Supplements Market in Great Britain by Value at Current Prices (£m at rsp and %), 2000/2001-2001/2002, 2003-2004 and 2004/2005-2006/2007
- Figure 1: The Total Vitamins, Minerals and Supplements Market in Great Britain by Value at Current Prices (£m at rsp), 2000/2001-2001/2002, 2003-2004 and 2004/2005-2006/2007
- Market Sectors
- Table 6: The Total Vitamins, Minerals and Supplements Market in Great Britain by Sector by Value at Current Prices (£m at rsp and %), 2004/2005-2006/2007
- DISTRIBUTION
- Table 7: The Vitamins, Minerals and Supplements Market in Great Britain by Sector by Retail Outlet Type by Value (%), 2006/2007
- COMPETITIVE STRUCTURE
- Overview
- Major Manufacturers' and Retailers' Shares
- Table 8: Major Manufacturers' and Own-Label Shares of the Vitamins, Minerals and Supplements Market in Great Britain by Value at Current Prices (%), 2004/2005-2006/2007
- ADVERTISING
- THE CONSUMER
- MARKET FORECASTS
- Table 9: The Forecast Vitamins, Minerals and Supplements Market in Great Britain by Value at Current Prices (£m at rsp), 2007/2008-2011/2012
- 3. Multivitamins
- BACKGROUND AND MARKET SIZE
- Table 10: The Multivitamins Sector in Great Britain by Value at Current Prices (£m at rsp and %), 2004/2005-2006/2007
- CONSUMER TRENDS
- ADVERTISING
- 4. Single Vitamins
- BACKGROUND AND MARKET SIZE
- Table 11: The Single Vitamins Sector in Great Britain by Value at Current Prices (£m at rsp and %), 2004/2005-2006/2007
- CONSUMER TRENDS
- ADVERTISING
- 5. Fish Oils
- BACKGROUND AND MARKET SIZE
- Table 12: The Fish Oils Sector in Great Britain by Value at Current Prices (£m at rsp and %), 2004/2005-2006/2007
- CONSUMER TRENDS
- ADVERTISING
- 6. Evening Primrose and Starflower Oils
- BACKGROUND AND MARKET SIZE
- Table 13: The Evening Primrose and Starflower Oils Sector in Great Britain by Value at Current Prices (£m at rsp and %), 2004/2005-2006/2007
- CONSUMER TRENDS
- ADVERTISING
- 7. Minerals and Other Supplements
- BACKGROUND AND MARKET SIZE
- Minerals
- Table 14: The Minerals Sector in Great Britain by Value at Current Prices (£m at rsp and %), 2004/2005-2006/2007
- Glucosamine
- Table 15: The Glucosamine Sector in Great Britain by Value at Current Prices (£m at rsp and %), 2004/2005-2006/2007
- Garlic
- Table 16: The Garlic Sector in Great Britain by Value at Current Prices (£m at rsp and %), 2004/2005-2006/2007
- Ginkgo
- Table 17: The Ginkgo Sector in Great Britain by Value at Current Prices (£m at rsp and %), 2004/2005-2006/2007
- Ginseng
- Table 18: The Ginseng Sector in Great Britain by Value at Current Prices (£m at rsp and %), 2004/2005-2006/2007
- St John's Wort
- Table 19: The St John's Wort Sector in Great Britain by Value at Current Prices (£m at rsp and %), 2004/2005-2006/2007
- Other Supplements
- Table 20: The `Other Supplements' Sector in Great Britain by Value at Current Prices (£m at rsp and %), 2004/2005-2006/2007
- CONSUMER TRENDS
- Glucosamine
- Garlic, Ginkgo and Ginseng
- ADVERTISING
- Minerals
- Glucosamine
- Garlic
- Ginkgo, Ginseng, St John's Wort and Other Supplements
- 8. Advertising and Promotion
- MAIN MEDIA ADVERTISING EXPENDITURE
- Table 21: Main Media Advertising Expenditure on Vitamins, Mineral and Supplements (£000), 2004/2005-2006/2007
- TRADE SHOWS
- 9. Distribution
- MARKET SHARES BY OUTLET TYPE
- Table 22: The Vitamins, Minerals and Supplements Market in Great Britain by Retail Outlet Type by Value (%), 2004/2005-2006/2007
- Figure 2: The Vitamins, Minerals and Supplements Market in Great Britain by Retail Outlet Type by Value (%), 2006/2007
- 10. An International Perspective
- WESTERN EUROPE AND SCANDINAVIA
- Austria
- Belgium
- Denmark
- Finland
- France
- Germany
- The Republic of Ireland
- Italy
- The Netherlands
- Norway
- Portugal
- Spain
- Sweden
- Switzerland
- 11. PEST Analysis
- POLITICAL FACTORS
- ECONOMIC FACTORS
- SOCIAL AND DEMOGRAPHIC FACTORS
- TECHNOLOGICAL FACTORS
- 12. Consumer Dynamics
- PRODUCT PENETRATION AND LEVELS OF USAGE
- Table 23: Those Who Had Taken Vitamins or Supplements in the Past 12 Months, and Those Taking Them Once per Day (% of respondents), 2006/2007
- Table 24: Regular Use of Selected Vitamins or Supplements by Type of Product (% of respondents), 2006/2007
- CONSUMERS' HABITS AND ATTITUDES REGARDING VITAMINS, MINERALS AND SUPPLEMENTS
- Overview
- Table 25: Summary of Results — Consumers' Habits and Attitudes Regarding Vitamins, Minerals and Supplements (% of respondents), August 2007
- Regular Use of Any Vitamin, Mineral or Supplement Product
- Table 26: Regular Use of Any Vitamin, Mineral or Supplement Product (% of respondents), August 2007
- Regular Use by Type of Product
- Multivitamins
- Table 27: Regular Use of Multivitamins (% of respondents), August 2007
- Single Vitamins
- Table 28: Regular Use of Single Vitamins (% of respondents), August 2007
- Cod Liver or Other Fish Oil
- Table 29: Regular Use of Cod Liver or Other Fish Oil (% of respondents), August 2007
- Evening Primrose or Starflower Oil
- Table 30: Regular Use of Evening Primrose or Starflower Oil (% of respondents), August 2007
- Garlic, Ginkgo or Ginseng
- Table 31: Regular Use of Garlic, Ginkgo or Ginseng (% of respondents), August 2007
- Glucosamine
- Table 32: Regular Use of Glucosamine (% of respondents), August 2007
- Belief That Requirements Are Met Adequately by Normal Diet
- Table 33: Little or No Use of Vitamin, Mineral or Supplement Products Due to the Belief that Requirements Are Met Adequately by Normal Diet (% of respondents), August 2007
- 13. Company Profiles
- BRANDED PRODUCTS
- Bayer Consumer Care — Bayer PLC
- Profitability
- Table 34: Financial Results for Bayer PLC (£000 and %), Years Ending 31st December 2004-2006
- BHM Health Group Ltd
- Profitability
- Table 35: Financial Results for BHM Health Group Ltd (£000 and %), Years Ending 29th February 2004, and 28th February 2005 and 2006
- Boehringer Ingelheim Ltd
- Profitability
- Table 36: Financial Results for Boehringer Ingelheim Ltd (£000 and %), Years Ending 31st December 2004-2006
- Chefaro UK Ltd
- Profitability
- Table 37: Financial Results for Chefaro UK Ltd (£000 and %), Years Ending 31st December 2004-2006
- Efamol Ltd
- Profitability
- Equazen UK Ltd
- Profitability
- Table 38: Financial Results for Equazen UK Ltd (£000 and %), Years Ending 31st December 2003-2005
- Ernest Jackson & Co Ltd
- Profitability
- Health Perception (UK) Ltd
- Profitability
- Table 39: Financial Results for Health Perception (UK) Ltd (£000 and %), Years Ending 31st December 2002 and 2003, and 65 Weeks Ending 31st March 2005
- Klosterfrau Healthcare (formerly Lichtwer Pharma AG)
- Profitability
- Potters Herbal Medicines — Potters Ltd
- Profitability
- Table 40: Financial Results for Potters Ltd (£000 and %), Years Ending 31st December 2004-2006
- Seven Seas Ltd
- Profitability
- Table 41: Financial Results for Seven Seas Ltd (£000 and %), Years Ending 31st December 2003-2005
- Solgar Vitamin & Herb
- Profitability
- Vitabiotics Ltd
- Profitability
- Table 42: Financial Results for Vitabiotics Ltd (£000 and %), Years Ending 31st December 2004-2006
- Wassen International Ltd
- Profitability
- Table 43: Financial Results for Wassen International Ltd (£000 and %), Years Ending 30th June 2004-2006
- Wyeth Consumer Healthcare
- Profitability
- Other Manufacturers of Brands
- Cultech Ltd
- Profitability
- DCC Health & Beauty Solutions Ltd (formerly DCC Nutraceuticals Ltd)
- Profitability
- Nature's Aid Ltd
- Profitability
- Pharma Nord
- Profitability
- Quest Vitamins Ltd
- Profitability
- RETAILERS' OWN LABELS
- Alliance Boots Ltd
- Profitability
- Table 44: Financial Results for Alliance Boots Ltd (£000 and %), Years Ending 31st March 2005-2007
- Holland & Barrett Retail Ltd
- Profitability
- Table 45: Financial Results for Holland & Barrett Retail Ltd (£000 and %), Years Ending 30th September 2004-2006
- Superdrug Stores PLC
- Profitability
- Table 46: Financial Results for Superdrug Stores PLC (£000 and %), Year Ending 25th December 2004, 53 Weeks Ending 31st December 2005 and Year Ending 30th December 2006
- Tesco Stores Ltd
- Profitability
- Table 47: Financial Results for Tesco Stores Ltd (£000 and %), 53 Weeks Ending 28th February 2004 and Years Ending 26th February 2005 and 25th February 2006
- Other Retailers' Own Labels
- MAIL ORDER AND THE INTERNET
- 14. The Future
- FUTURE TRENDS
- FORECASTS
- Table 48: The Forecast Vitamins, Minerals and Supplements Market in Great Britain by Sector by Value at Current Prices (£m at rsp), 2007/2008-2011/2012
- Figure 3: The Forecast Vitamins, Minerals and Supplements Market in Great Britain by Value at Current Prices (£m at rsp), 2007/2008-2011/2012
- 15. Further Sources
- Associations
- Major Manufacturers and Suppliers
- Trade Publications
- Market Research Organisations
- General Sources
- Government Publications
- Bisnode Sources
AbstractThe market for vitamins, minerals and supplements (VMS) grew by only 0.4% in value terms in the 12 months ending August 2007. This follows a history of market declines in 2001 and 2002, significant growth in 2003 and 2004, but only marginal growth since then. Virtually all growth has been in supplements, with vitamin products accounting for just over 30% of the market in 2006/2007 by value, and minerals and supplements representing nearly 70%. The VMS market is forecast to grow only slowly over the next 5 years (to 2011/2012).
The ageing population profile of the UK will continue to benefit VMS products sales, since, in general, consumption rises with age. Manufacturers are increasingly producing supplements more specifically targeted at age-related conditions, such as those affecting the heart, the brain, the eyes and joints; the most successful products in recent years have been glucosamines and omega-3 fish oils. In addition, there is an overall greater interest shown in a healthier lifestyle, and greater affluence among the older population than previously.
However, the market has been held back by the periodic publication of research studies concluding that many of those taking VMS products do so unnecessarily. It is, nonetheless, agreed that certain groups of people do benefit from their consumption. There is no scientific proof that supplementing the diet generally with extra vitamins or minerals is beneficial, and there could be a danger of overconsumption.
In addition, the VMS market has been under threat since 2002 from the EU's Food Supplement Directive (FSD), which is charged with setting maximum recommended daily consumption levels for all VMS formulations, and organising manufacturers to provide data in order to gain safety approvals for their VMS products. Some products already appear on the FSD's `positive list', but many others are as yet not approved, and will therefore not be able to be sold after 31st December 2009 (unless they obtain approval). This whole initiative has proved to be a substantial undertaking, and — although it was scheduled for completion in 2005 — remains still largely under discussion.
Multivitamins and fish oils continue to represent the largest segments of the VMS market, followed by single vitamins and, now, glucosamines. Sales in several sectors of the market are declining, although those of multivitamins, single vitamins and minerals appear to have stabilised.
Chemist and druggist shops are still estimated to account for the largest, and now stable, share of sales of VMS products — headed by Alliance Boots. Earlier, they had been losing share to grocery multiples, after the removal of resale price maintenance (RPM) on over-the-counter (OTC) medicines in 2001. The share held by grocery multiples also appears to have now stabilised, led by Tesco. Health-food shops still account for a large but slowly declining share of sales, dominated by Holland & Barrett, while a small but growing market share is held by direct-selling channels such as mail order and the Internet.
Seven Seas is by far the largest manufacturer of branded VMS products, with a very wide range covering most segments. Bayer, which has acquired Roche's retail VMS business, lies in second place within brands, specialising in vitamin products. Many other smaller suppliers of brands specialise in particular segments of the market. However, a large market share within VMS is held by retailers' own-label products, notably those of Holland & Barrett and Alliance Boots.
There have been a number of changes among manufacturers in the VMS market in recent years. Apart from Bayer's acquisition of Roche's retail vitamins business, Galenica has acquired Potters Herbal Medicines — which has then bought certain VMS products from Chefaro and Boehringer Ingelheim, and also the manufacturer Equazen; William Ransom has acquired Health Perception; Solgar has been bought by NBTY; and Efamol has been acquired by Wassen.
Get Full Details About This Report >>
|
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|